Literature DB >> 6187272

Improved method for assay of estradiol and progesterone receptors with special reference to breast cancer.

A Norgren, A Borg, M Fernö, U Johansson, B Lindahl, K Tsiobanelis.   

Abstract

Isoelectric focusing of estradiol receptor (ER) and multiple point dextran-coated charcoal (DCC) technique for progesterone receptor (PgR) were adapted for assay of both receptors in the same cytosol sample. Technical improvements and increased recovery of receptors were achieved. 1.0 fmol/ml cytosol of ER may be detected; sensitivity of PgR was 5-10 fmol/ml cytosol. Quantitation of ER was made in 414 (95%) out of 434 consecutive breast cancers. Inclusion of isoelectric focusing records showing only qualitative indication for presence of ER resulted in 98% ER containing tumours, supporting the aspect that strictly ER negative tumours are a rarity. Implications for therapy in disseminated disease are discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6187272

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  A biological marker, strongly associated with early oral contraceptive use, for the selection of a high risk group for premenopausal breast cancer.

Authors:  H Olsson; A Borg; S B Ewers; M Fernö; T Möller; J Ranstam
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

2.  Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas--a 10 year survival study.

Authors:  S B Ewers; R Attewell; B Baldetorp; A Borg; M Fernö; E Långström; D Killander
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

3.  Cellular retinol-binding protein in normal and neoplastic human mammary gland.

Authors:  G Fex; F Linell; O Ljungberg
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

4.  Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis.

Authors:  A Borg; H Sigurdsson; G M Clark; M Fernö; S A Fuqua; H Olsson; D Killander; W L McGurie
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

5.  Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosols.

Authors:  A Borg; J Lennerstrand; M Stenmark-Askmalm; M Fernö; A Brisfors; A Ohrvik; O Stål; D Killander; D Lane; J Brundell
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.